Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '148 Examiner Interview Summary Record now posted at USPTO

I guess we're getting close to a decision. It seems likely that Moore will be able to demonstrate the differences to the prior art in his written response IMHO. Assuming they understand his arguments and they have no more questions are there any other possible options for their next Office Action other than rejection or acceptance?

GLTAL

Share
New Message
Please login to post a reply